Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malka

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|October 26, 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancerJérôme Cartry, Sabrina Bedja, Alice Boilève, et al.
The Lancet. Oncology|February 5, 2023
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trialThomas Walter, Astrid Lievre, Romain Coriat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II TrialMaximiliano Gelli, Jacques Ewald, Marie-Laure Tanguy, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significanceSimon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohortAntoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
JHEP Reports : Innovation in Hepatology|October 13, 2025
Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomesThomas Pudlarz, Anthony Turpin, Natalia Soledad Tissera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 21, 2017
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II studyThomas Walter, David Malka, Olivia Hentic, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Journal of Experimental & Clinical Cancer Research : CR|October 26, 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancerJérôme Cartry, Sabrina Bedja, Alice Boilève, et al.
The Lancet. Oncology|February 5, 2023
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trialThomas Walter, Astrid Lievre, Romain Coriat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II TrialMaximiliano Gelli, Jacques Ewald, Marie-Laure Tanguy, et al.
Therapeutic Advances in Medical Oncology|October 6, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)Marine Valery, Julien Edeline, Julie Henriques, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 4, 2019
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significanceSimon Pernot, Magali Terme, Nina Radosevic-Robin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohortAntoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 27, 2023
Features of colorectal adenomas among young patients with Lynch syndrome according to path_MMR: Results from the PRED-IdF registryHadrien Alric, Elise Coffin, Celine Lekhal, et al.
The Lancet Regional Health. Europe|May 19, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]Lorenza Rimassa, Angela Lamarca, Grainne M O'Kane, et al.
JHEP Reports : Innovation in Hepatology|October 13, 2025
Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomesThomas Pudlarz, Anthony Turpin, Natalia Soledad Tissera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 21, 2017
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II studyThomas Walter, David Malka, Olivia Hentic, et al.
Pageof 20